Phase I and pharmacologic studies of pyrazoloacridine, a novel DNA intercalating agent, on single-dosing and multiple-dosing schedules

Eric K. Rowinsky, Dennis A. Noe, Louise B. Grochow, Susan E. Sartorious, M. Kathy Bowling, Tian Ling Chen, Barbara G. Lubejko, Scott H. Kaufmann, Ross C. Donehower

Research output: Contribution to journalArticlepeer-review

33 Scopus citations

Fingerprint Dive into the research topics of 'Phase I and pharmacologic studies of pyrazoloacridine, a novel DNA intercalating agent, on single-dosing and multiple-dosing schedules'. Together they form a unique fingerprint.

Medicine & Life Sciences